NO20015972D0 - Screeningsmetoder for å endre dögnrytmeproteiner - Google Patents
Screeningsmetoder for å endre dögnrytmeproteinerInfo
- Publication number
- NO20015972D0 NO20015972D0 NO20015972A NO20015972A NO20015972D0 NO 20015972 D0 NO20015972 D0 NO 20015972D0 NO 20015972 A NO20015972 A NO 20015972A NO 20015972 A NO20015972 A NO 20015972A NO 20015972 D0 NO20015972 D0 NO 20015972D0
- Authority
- NO
- Norway
- Prior art keywords
- alter
- ability
- directed
- screening methods
- phosphorylation
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Biophysics (AREA)
- Organic Chemistry (AREA)
- Toxicology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Electrophonic Musical Instruments (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US32774599A | 1999-06-08 | 1999-06-08 | |
| PCT/US2000/015633 WO2000075669A1 (en) | 1999-06-08 | 2000-06-07 | Screening methods for altering circadian rhythm proteins |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO20015972D0 true NO20015972D0 (no) | 2001-12-06 |
| NO20015972L NO20015972L (no) | 2002-02-05 |
| NO330241B1 NO330241B1 (no) | 2011-03-14 |
Family
ID=23277866
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20015972A NO330241B1 (no) | 1999-06-08 | 2001-12-06 | Fremgangsmate for a identifisere forbindelser som endrer fosforylering av det humane klokkeproteinet hPERIODE1 (hPER1) |
| NO20100430A NO20100430L (no) | 1999-06-08 | 2010-03-23 | Anvendelse av en forbindelse for fremstilling av et medikament for a endre den cirkadiske rytme hos et pattedyr |
| NO20100431A NO20100431L (no) | 1999-06-08 | 2010-03-23 | Fremgangsmate for a endre degradering av det humane klokkeproteinet hPeriode1 (hPER1) |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20100430A NO20100430L (no) | 1999-06-08 | 2010-03-23 | Anvendelse av en forbindelse for fremstilling av et medikament for a endre den cirkadiske rytme hos et pattedyr |
| NO20100431A NO20100431L (no) | 1999-06-08 | 2010-03-23 | Fremgangsmate for a endre degradering av det humane klokkeproteinet hPeriode1 (hPER1) |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US6555328B1 (no) |
| EP (1) | EP1183541B1 (no) |
| JP (1) | JP4583682B2 (no) |
| KR (1) | KR100722176B1 (no) |
| AT (1) | ATE322016T1 (no) |
| AU (1) | AU767800B2 (no) |
| BR (1) | BR0011437A (no) |
| CA (1) | CA2375450C (no) |
| DE (1) | DE60026998T2 (no) |
| IL (2) | IL146729A0 (no) |
| MX (1) | MXPA01011417A (no) |
| NO (3) | NO330241B1 (no) |
| NZ (1) | NZ514603A (no) |
| WO (1) | WO2000075669A1 (no) |
| ZA (1) | ZA200108962B (no) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6476188B1 (en) | 1998-06-19 | 2002-11-05 | The Rockefeller University | Clock gene and methods of use thereof |
| US6436628B1 (en) | 1998-06-19 | 2002-08-20 | The Rockefeller University | Methods of identifying an agent which modulates period and doubletime protein interaction |
| NZ514603A (en) * | 1999-06-08 | 2003-10-31 | Aventis Pharma Inc | Test compounds that alter the ability of human casein kinase 1 delta and/or epsilon to phosphorylate the human clock proteins |
| ATE432354T1 (de) * | 1999-11-18 | 2009-06-15 | Mitsubishi Tanabe Pharma Corp | Transgene säugetiere mit einem period 1 promotor, der rhythmische expression verleiht |
| GB0103110D0 (en) * | 2000-08-25 | 2001-03-28 | Aventis Pharma Inc | A membrane penetrating peptide encoded by a nuclear localization sequence from human period 1 |
| AU2002248338A1 (en) * | 2001-01-11 | 2002-07-24 | University Of Utah Research Foundation | Identification of an advanced sleep phase syndrome gene in humans |
| AU2003278333A1 (en) * | 2002-10-25 | 2004-05-13 | University Of Surrey | Polymorphism in the per3 gene as a indicator in the diagnosis and treatment of circadian rhythm sleep disorders |
| EP1576133A2 (en) * | 2002-11-27 | 2005-09-21 | University of Utah Research Foundation | Casein kinase i epsilon and casein kinase i delta and sleep in humans |
| ES2334927T3 (es) * | 2004-08-19 | 2010-03-17 | Aventis Pharmaceuticals Inc. | Derivados de 3-ariltioindol-2-carboxamida y sus analogos como imhibidores de caseina quinasa i. |
| JO2629B1 (en) * | 2004-08-19 | 2012-06-24 | افينتيس فارما سوتيكالز انك | Branched carboxylic acid amides containing thienobirol, carboxylic acid amides containing pyrolithiazole, and the like as kinase inhibitors casein epsilon |
| JO2724B1 (en) * | 2004-08-19 | 2013-09-15 | افينتس فارماسوتيكالز انك | 3-Alternative-5 -6-Amino Alkyl Indole-2-Carboxyl Acid Amide and Related Isotopes as Casein Kinase Inhibitors |
| WO2007139229A1 (en) * | 2006-05-31 | 2007-12-06 | National Institute Of Radiological Sciences | Light-inducible and rhythmically expressed genes and method for screening substances that affect an internal clock system |
| EP2077838B1 (en) * | 2006-10-25 | 2013-04-03 | The Rockefeller University | Methods for the treatment of amyloid-beta related disorders and compositions therefor |
| FR2918986B1 (fr) | 2007-07-19 | 2009-09-04 | Sanofi Aventis Sa | Derives de 6-cycloamino-3-(pyridazin-4-yl)imidazo[1,2-b]- pyridazine, leur preparation et leur application en therapeutique |
| CN105744948B (zh) * | 2013-10-14 | 2020-03-24 | 南京大学 | 进食节律提前综合征的识别方法及其应用 |
| KR101600144B1 (ko) | 2013-12-20 | 2016-03-04 | 서울대학교산학협력단 | 일주기 리듬 수면장애 및 시차 부적응에 대한 예방 또는 치료제 스크리닝 방법 |
| US9944648B2 (en) | 2014-01-09 | 2018-04-17 | Intra-Cellular Therapies, Inc. | Organic compounds |
| US11116754B2 (en) | 2015-11-13 | 2021-09-14 | The Trustees Of Columbia University In The City Of New York | Inhibition of TOR complex 2 increases immunity against bacterial infection |
| WO2023129377A1 (en) * | 2022-01-03 | 2023-07-06 | The Johns Hopkins University | Methods and materials for treating heart attack |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH1157137A (ja) * | 1997-08-28 | 1999-03-02 | Sanyo Bussan Kk | 遊技機用特別図柄表示装置 |
| KR100246893B1 (ko) * | 1997-12-29 | 2000-05-01 | 윤종용 | 전자렌지용 도어 |
| AU3976099A (en) * | 1998-05-07 | 1999-11-23 | President & Fellows Of Harvard College, The | Compositions and methods involving regulation of mammalian circadian rhythms |
| NZ514603A (en) * | 1999-06-08 | 2003-10-31 | Aventis Pharma Inc | Test compounds that alter the ability of human casein kinase 1 delta and/or epsilon to phosphorylate the human clock proteins |
-
2000
- 2000-06-07 NZ NZ514603A patent/NZ514603A/en not_active IP Right Cessation
- 2000-06-07 AU AU54689/00A patent/AU767800B2/en not_active Ceased
- 2000-06-07 DE DE60026998T patent/DE60026998T2/de not_active Expired - Lifetime
- 2000-06-07 US US09/589,462 patent/US6555328B1/en not_active Expired - Lifetime
- 2000-06-07 AT AT00939629T patent/ATE322016T1/de active
- 2000-06-07 CA CA002375450A patent/CA2375450C/en not_active Expired - Fee Related
- 2000-06-07 KR KR1020017015764A patent/KR100722176B1/ko not_active IP Right Cessation
- 2000-06-07 IL IL14672900A patent/IL146729A0/xx active IP Right Grant
- 2000-06-07 EP EP00939629A patent/EP1183541B1/en not_active Expired - Lifetime
- 2000-06-07 JP JP2001501893A patent/JP4583682B2/ja not_active Expired - Fee Related
- 2000-06-07 MX MXPA01011417A patent/MXPA01011417A/es active IP Right Grant
- 2000-06-07 BR BR0011437-5A patent/BR0011437A/pt not_active Application Discontinuation
- 2000-06-07 WO PCT/US2000/015633 patent/WO2000075669A1/en active IP Right Grant
-
2001
- 2001-10-30 ZA ZA200108962A patent/ZA200108962B/en unknown
- 2001-11-25 IL IL146729A patent/IL146729A/en not_active IP Right Cessation
- 2001-12-06 NO NO20015972A patent/NO330241B1/no not_active IP Right Cessation
-
2010
- 2010-03-23 NO NO20100430A patent/NO20100430L/no not_active Application Discontinuation
- 2010-03-23 NO NO20100431A patent/NO20100431L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| BR0011437A (pt) | 2002-03-05 |
| NO20100430L (no) | 2002-02-05 |
| CA2375450A1 (en) | 2000-12-14 |
| CA2375450C (en) | 2009-04-28 |
| NO20015972L (no) | 2002-02-05 |
| IL146729A (en) | 2007-06-17 |
| AU5468900A (en) | 2000-12-28 |
| JP2003501074A (ja) | 2003-01-14 |
| AU767800B2 (en) | 2003-11-27 |
| KR100722176B1 (ko) | 2007-05-29 |
| EP1183541A1 (en) | 2002-03-06 |
| EP1183541B1 (en) | 2006-03-29 |
| ATE322016T1 (de) | 2006-04-15 |
| NO20100431L (no) | 2002-02-05 |
| ZA200108962B (en) | 2003-01-30 |
| WO2000075669A1 (en) | 2000-12-14 |
| NO330241B1 (no) | 2011-03-14 |
| DE60026998T2 (de) | 2007-04-05 |
| DE60026998D1 (de) | 2006-05-18 |
| IL146729A0 (en) | 2002-07-25 |
| NZ514603A (en) | 2003-10-31 |
| US6555328B1 (en) | 2003-04-29 |
| MXPA01011417A (es) | 2002-06-04 |
| JP4583682B2 (ja) | 2010-11-17 |
| KR20020033101A (ko) | 2002-05-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20100431L (no) | Fremgangsmate for a endre degradering av det humane klokkeproteinet hPeriode1 (hPER1) | |
| CY1110679T1 (el) | Νουκλεοτιδικες και πρωτεϊνικες ακολουθιες γονιδιων nogo και μεθοδοι βασιζομενες σε αυτες | |
| CY1105836T1 (el) | 12, 13-τροποποιημενα παραγωγα εποθιλονης | |
| EA199900758A1 (ru) | Малые молекулы, полезные при лечении воспалительных заболеваний | |
| ATE279181T1 (de) | Verwendung von 5ht-6 antagonisten zur behandlung adhd | |
| CY1112055T1 (el) | Συνθεσεις και μεθοδοι για την διαγνωση και θεραπευτικη αγωγη ογκου πνευμονα | |
| EA200100589A1 (ru) | Азабициклоалканы как модуляторы ccr5 | |
| EA200400241A1 (ru) | Направленные к мишени мультимерные контрастные вещества, основанные на пептидах | |
| BR0316502A (pt) | Compostos quìmicos | |
| EA200100588A1 (ru) | Пиперидины как модуляторы ccr5 | |
| ATE269303T1 (de) | Arylpiperazinyl-cyclohexyl indolderivate zur behandlung von depressionen | |
| BR0111125A (pt) | Moléculas de ácido nucléico de nrg-2, polipeptìdeos, e métodos diagnóstico e terapêuticos | |
| DE69821667D1 (de) | Kardioverter zur Behandlung von Vorhofflattern | |
| ES2183351T3 (es) | Composicones que comprenden conjugados de proteina ob humana activa estable con una cadena fc de inmunoglobulinas y metodos. | |
| ATE350030T1 (de) | Nordihydroguaiaretinsäurederivate zur behandlung von tumoren | |
| EA200100012A1 (ru) | Мостиковые инденопирролокарбазолы | |
| ATE218857T1 (de) | Verwendung von gabapentin und seine derivate in der behandlung von manie und bipolare störungen | |
| CY1105380T1 (el) | Προτιμωμενα τμηματα της νευρικης νηματικης πρωτεϊνης και μεθοδοι χρησης αυτων | |
| PT948604E (pt) | Produtos e metodos relacionados com pyk2 | |
| DE3854209D1 (de) | Analyse von organischen Substanzen. | |
| EA200500603A1 (ru) | ПРОИЗВОДНЫЕ [6,7-ДИГИДРО-5H-ИМИДАЗО[1,2-α]ИМИДАЗОЛ-3-СУЛЬФОНИЛАМИНО]ПРОПИОНАМИДА | |
| ATE73995T1 (de) | Verwendung von penicillamin zur behandlung von immunmangelkrankheiten. | |
| DE69606837D1 (de) | Gerät zur Überprüfung der Bestimmungen von klinischen Analysen | |
| ATE187442T1 (de) | Tryptamine zur behandlung von störungen der circadianen rhythmik | |
| ATE261724T1 (de) | Antikonvulsive derivate zur behandlung von posttraumatischen stresserkrankungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |